Article Text

Download PDFPDF
Febrile neutropenia: transition towards a risk-directed approach
  1. P Anoop1,
  2. M A Anjay2
  1. 1Paediatric Haemato-oncology, Royal Marsden Hospital, Surrey, UK
  2. 2Paediatrics, Airedale General Hospital, Keighley, West Yorkshire, UK
  1. Correspondence to:
    P Anoop
    Paediatric Haemato-oncology, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK; docanoop{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Phillips et al have appropriately brought to light the lack of consistency in the treatment of chemotherapy induced febrile neutropenia in children.1 We agree with the authors that formulation of a national guideline will help to simplify and streamline the approach to this common problem in paediatric oncology.

The authors have suggested that it may be possible to treat some children with antibiotic regimens of reduced intensity and duration, based on risk stratification. However, most such studies quoted were based on adult data. The few paediatric studies mentioned did not …

View Full Text


  • Competing interests: None declared.